• World
    • Africa
    • Asia Pacific
    • Central & South Asia
    • Europe
    • Latin America & Caribbean
    • Middle East & North Africa
    • North America
  • Coronavirus
  • Politics
    • US Election
    • US politics
    • Joe Biden
    • Brexit
    • European Union
    • India
    • Arab world
  • Economics
    • Finance
    • Eurozone
    • International Trade
  • Business
    • Entrepreneurship
    • Startups
    • Technology
  • Culture
    • Entertainment
    • Music
    • Film
    • Books
    • Travel
  • Environment
    • Climate change
    • Smart cities
    • Green Economy
  • Global Change
    • Education
    • Refugee Crisis
    • International Aid
    • Human Rights
  • International Security
    • ISIS
    • War on Terror
    • North Korea
    • Nuclear Weapons
  • Science
    • Health
  • 360 °
  • The Interview
  • In-Depth
  • Insight
  • Quick Read
  • Video
  • Podcasts
  • Interactive
  • My Voice
  • About
  • FO Store
Sections
  • World
  • Coronavirus
  • Politics
  • Economics
  • Business
  • Culture
  • Sign Up
  • Login
  • Publish

Make Sense of the world

Unique insight from 2,000+ contributors in 80+ Countries

Close

What’s Behind Chile’s Vaccination Success?

With 20% of its population inoculated, Chile is in the top five globally and far ahead of its neighbors when it comes to vaccination rates.
By Lenin Cavalcanti Guerra • Mar 05, 2021
Lenin Cavalcanti Guerra, Chile vaccination program, Latin America COVID-19, Brazil COVID-19 news, Argentina vaccination scandal, Jair Bolsonaro COVID-19 denialism, Brazil COVID-19 measures, Sebastian Pinera Chile news, Chile COVID-19 management, top COVID vaccination countries

COVID-19 vaccine administered in Copiapó, Chile, 2021 © Israel Chavez Rojas / Shutterstock

The deadly impact of COVID-19 has been felt in every corner of the globe. On February 22, the United States reached a tragic landmark of 500,000 deaths. Across the Atlantic, nine of the top 10 nations in deaths per million are in Europe, with tiny enclaves of Gibraltar and San Marino topping the tables. The list of countries that have dealt with the pandemic relatively well is much shorter. Almost a year ago, I wrote about how leaders in Brazil and Mexico were slow in taking tougher action to prevent the spread of the virus. I falsely predicted that Latin America is unlikely to witness the death rates seen in Europe. Unfortunately, the effects of the pandemic were equally devastating in the region, if not worse.

Images of mass graves in the Amazonian town of Manaus and the dead bodies left in coffins in the streets of Guayaquil, Ecuador, have spread worldwide. More than 260,000 Brazilians and nearly 190,000 Mexicans died because of the virus, placing the two countries second and third in absolute numbers of fatalities. Peru registered 1,421 deaths per million and Panama 1,352 on March 4 — numbers that show the devastation caused by the virus in the region so far. Chile has also experienced a significant death rate of 1,084 per million.


Why Are Mexico and Brazil So Slow in Reacting to COVID-19?

READ MORE


The big difference in Chile was that authorities mobilized in advance to secure vaccines, hedging bets on various suppliers in different stages of development. In September last year, President Sebastian Pinera announced the purchase of 10 million doses of Pfizer-BioNtech vaccine. Deliveries commenced on December 24, making Chile the first Latin American nation to start its vaccination program. The country has ordered some 90 million doses, more than enough to immunize its 19 million citizens. By March 4, more than 20% of its population received at least one shot, placing Chile fifth in the world when it comes to vaccination rates, just behind Israel, United Arab Emirates, the United Kingdom and the United States.

Political Conflict

On December 29, Argentinians started to receive the Russian Sputnik V vaccine. The pace of immunization in Argentina has been much slower than expected, with several complaints of those not in priority groups receiving the jab before health workers and the elderly. The “VIP vaccination” scandal has caused the resignation of the health minister, drawing protesters onto the streets and generating criticism against President Alberto Fernandez. So far, Argentina has vaccinated only 2.61% of its 45 million citizens. The slower pace seems to be standard in the region, with most nations unable to vaccinate even 1% of their citizens. The cause is not only the shortage of vaccines but lack of planning and, more significantly, internal political conflict. 

In Brazil, president Jair Bolsonaro has made several statements that undermined efforts to slow the pandemic. In a national broadcast on March 24, 2020, he criticized the restrictive measures adopted by governors and mayors, urging people to return to work and referring to COVID-19 as a “little flu.” The president also highly publicized the unproven anti-malarian drug chloroquine as being effective against the virus, ordering the Ministry of Health to produce four million doses. His insistence on the use of the drug caused the loss of two health ministers, Dr. Henrique Mandetta, fired by Bolsonaro last April, and Dr. Nelson Teich, who resigned less than a month after taking over. Since then, the position has been filled by an army general specializing in logistics, with neither medical education nor experience.

logo

Make Sense of the World

Unique insight from 2,000+ contributors in 80+ Countries

Make Sense of the World
Unique insights from 2000+ contributors in 80+ countries

Over the course of the pandemic, Bolsonaro has been exchanging public barbs with the state governments, such as over lockdown measures adopted by individual governors last month. On March 1, 16 of the country’s 26 governors, including three Bolsonaro allies, signed a letter criticizing the government and accusing the president of misleading the public about federal pandemic relief funds. Sao Paulo’s governor, Joao Doria, a former ally in the 2018 elections and a potential competitor in 2022, has been the president’s most vociferous antagonist over the handling of the pandemic.

At the center of the dispute is the Butantan Institute, one of the most prestigious health centers in Latin America, situated in the state of Sao Paolo. Back in June, Butantan signed a partnership with the Chinese laboratory Sinovac Biotech to produce the CoronaVac vaccine. Initially, Bolsonaro has signaled that Brazil would not purchase the Chinese vaccine, questioning its efficiency, but in January, the Ministry of Health added the vaccine to the national immunization plan following approval by the health regulator, Anvisa. Last month, Doria announced a deal for a further 20 million doses of CoronaVac to complement the 100 million already secured by Butantan.

Last August, Pfizer said it offered 70 million batches of its vaccine to Brazil, with a delivery scheduled for December. However, with Brazil dissatisfied with the terms of the contract, the deal is still being negotiated. Health Minister Eduardo Pazuello hopes to secure 100 million doses from Pfizer and 38 million from a pharmaceutical subsidiary of Johnson & Johnson, Janssen, to start deliveries in May and August respectively. Due to this lack of urgency and an absence of a unified policy between the federal and state governments, Brazil has so far vaccinated just 3,67% of its population.

Crisis Management

Chile has also faced political unrest. Since 2019, the country experienced several mass protests calling for education and pension reforms. In a televised address, President Pinera declared a state of emergency, granting powers to restrain freedom of movement and assembly. The measure resulted in violence that cost 18 lives in five days, leading the UN to examine possible human rights abuses. As a result, Pinera’s approval rating fell to just 7%. In 2020, amid the ongoing political crisis, COVID-19 hit the country hard, provoking the resignation of the health minister, Jaime Manalich.

However, Pinera managed to turn the situation around. With a degree in commercial engineering from the Catholic University of Chile and a PhD in economics from Harvard, the president is a billionaire businessman, with an estimated net worth of $2,9 billion. He has already led the country once, between 2010 and 2014, earning crucial government nous. Pinera made several concessions to the protesters and supported the calls for a new constitution in an attempt to turn down the political temperature.  

A referendum on October 25 saw 78% of the population approve a new constitution that will substitute the current one created in 1980 under General Augusto Pinochet. The new Magna Carta will be written by a 155-strong body also elected through a popular vote and with an equal number of men and women. The document will then be confirmed by a popular vote before being implemented.

Embed from Getty Images

To assuage popular discontent caused by the initial handling of the pandemic in combination with other historical grievances relating to health care, education and pensions, Pinera focused his negotiation abilities to mediate the purchase of million doses of vaccine from different laboratories and suppliers. While most developing nations have been struggling with a lack of supplies, Chile is among the top three countries, along with Canada and the UK, when it comes to the number of doses ordered per capita. Back in September, just before the peak of protests, Pinera announced partnerships on the development and clinical trials between the Catholic University of Chile and Sinovac; the University of Chile, Janssen/Johnson & Johnson and AstraZeneca; as well as the University of Frontera and another Chinese laboratory, CanSino Biologics. More than that, purchases were agreed with Pfizer, Covax, Sinovac and AstraZeneca.

But despite perceived goodwill from an unpopular right-wing government, the president still faces an uphill climb when it comes to popularity. By March 1, 83% of the Chileans deemed the massive vaccination as good or very good, 58% asses the general management of the pandemic as positive, but Pinera’s personal approval is still only at 24%.

The successful vaccination has already yielded positive outcomes. According to Chile’s Health Ministry, the number of new COVID-19 cases has decreased in six of the country’s 16 regions in the last seven days and in eight the last 14 days. Chile hopes to vaccinate at least 15 million people in the first semester, which would allow the country to immunize its entire population by the end of June. These numbers would put Chile way ahead in the vaccination game not only in Latin America but worldwide, suggesting that resolute leadership is as important for the nation’s well-being as a robust medical system.

The views expressed in this article are the author’s own and do not necessarily reflect Fair Observer’s editorial policy.

Share Story
CategoriesCoronavirus, Insight, Latin America & the Caribbean, Politics, South America News, World Leaders News, World News TagsArgentina vaccination scandal, Brazil COVID-19 measures, Brazil COVID-19 news, Chile COVID-19 management, Chile vaccination program, Jair Bolsonaro COVID-19 denialism, Latin America COVID-19, Lenin Cavalcanti Guerra, Sebastian Pinera Chile news, top COVID vaccination countries
Join our network of more than 2,000 contributors to publish your perspective, share your story and shape the global conversation. Become a Fair Observer and help us make sense of the world.

Post navigation

Previous PostPrevious The Talented Mr. Bin Salman
Next PostNext Lebanon Hits a New Milestone
Subscribe
Register for $9.99 per month and become a member today.
Publish
Join our community of more than 2,500 contributors to publish your perspective, share your narrative and shape the global discourse.
Donate
We bring you perspectives from around the world. Help us to inform and educate. Your donation is tax-deductible.

Explore

  • About
  • Authors
  • FO Store
  • FAQs
  • Republish
  • Privacy Policy
  • Terms of Use
  • Contact

Regions

  • Africa
  • Asia Pacific
  • Central & South Asia
  • Europe
  • Latin America & Caribbean
  • Middle East & North Africa
  • North America

Topics

  • Politics
  • Economics
  • Business
  • Culture
  • Environment
  • Global Change
  • International Security
  • Science

Sections

  • 360°
  • The Interview
  • In-Depth
  • Insight
  • Quick Read
  • Video
  • Podcasts
  • Interactive
  • My Voice

Daily Dispatch


© Fair Observer All rights reserved
We Need Your Consent
We use cookies to give you the best possible experience. Learn more about how we use cookies or edit your cookie preferences. Privacy Policy. My Options I Accept
Privacy & Cookies Policy

Edit Cookie Preferences

The Fair Observer website uses digital cookies so it can collect statistics on how many visitors come to the site, what content is viewed and for how long, and the general location of the computer network of the visitor. These statistics are collected and processed using the Google Analytics service. Fair Observer uses these aggregate statistics from website visits to help improve the content of the website and to provide regular reports to our current and future donors and funding organizations. The type of digital cookie information collected during your visit and any derived data cannot be used or combined with other information to personally identify you. Fair Observer does not use personal data collected from its website for advertising purposes or to market to you.

As a convenience to you, Fair Observer provides buttons that link to popular social media sites, called social sharing buttons, to help you share Fair Observer content and your comments and opinions about it on these social media sites. These social sharing buttons are provided by and are part of these social media sites. They may collect and use personal data as described in their respective policies. Fair Observer does not receive personal data from your use of these social sharing buttons. It is not necessary that you use these buttons to read Fair Observer content or to share on social media.

 
Necessary
Always Enabled

These cookies essential for the website to function.

Analytics

These cookies track our website’s performance and also help us to continuously improve the experience we provide to you.

Performance
Uncategorized

This cookie consists of the word “yes” to enable us to remember your acceptance of the site cookie notification, and prevents it from displaying to you in future.

Preferences
Save & Accept